Migraine Tracking Tool from Aimovig® (erenumab-aooe)

Approved Use: Aimovig^® is a prescription medicine used for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Who should not use Aimovig^®?

Do not use Aimovig^® if you are allergic to erenumab-aooe or any ingredients in Aimovig^®.

Before starting Aimovig^®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig^®?

Aimovig^® may cause serious side effects, including:

Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig^®. This can happen within hours to days after using Aimovig^®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
Constipation with serious complications. Severe constipation can happen after receiving Aimovig^®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.
High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig^®. Contact your healthcare provider if you have an increase in blood pressure.

The most common side effects of Aimovig^® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig^®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for the full Prescribing Information and Patient Product Information.

APPROVED USE

Aimovig^® is a prescription medicine used for the preventive treatment of migraine in adults.

sign up for the tracker

*Required information

Date of Birth

(Message and data rates may apply)

*Telephone Consumer Protection Act (TCPA) Consent. I consent to receive marketing calls and texts from and on behalf of Amgen, made with an autodialer or prerecorded voice, at the phone number(s) provided. I understand that my consent is not required as a condition of purchase. The number of messages will vary based on your program selections. Message and data rates may apply. Text STOP to opt out and HELP for help.

*Gender

Male

Female

Non-Binary

Prefer Not to Answer

Date when you will take your next dose of your monthly preventive migraine medication

Please read and accept Patient Authorization and Program Terms & Conditions

Patient Authorization

I authorize Amgen and its contractors and business partners (“Amgen” ) to use and/or disclose my personal information, including my personal health information, for the following purposes: to operate, administer, enroll me in and/or continue my participation in Amgen’s text based digital migraine tracker and related activities; to provide me with informational and promotional materials relating to Amgen products and services, and/or my condition or treatment; and/or to improve, develop, and evaluate products, services, materials and programs related to my condition or treatment.
I consent to Amgen contacting me about the text based digital migraine tracker using the information provided in this form. Amgen may contact me using an automatic dialing machine, prerecorded voice or SMS/text message (standard text messaging rates may apply).
Reply STOP to cancel messages.
I further understand that the text based digital migraine tracker and additional informational and marketing communications related to my condition and treatment are optional and free services. I do not have to sign this authorization and this authorization in no way affects my right to obtain any medications. For further information about Amgen’s privacy practices please see https://www.migraineprivacypolicy.com and for terms of use, please see www.migrainetermsofuse.com.

By clicking “Submit your info,” I agree to enroll in the text based digital migraine tracker, and to receive marketing communications from Amgen. I can opt-out at any time.

Program Terms & Conditions

Aimovig’s Migraine Tracker short message service (SMS) symptom tracking program (the ‘Service’) runs on the short code 246-44. Amgen Inc, will not charge you to use this Service; however your Wireless Service Provider may charge you for sending and/or receiving messages and for airtime. Participants will receive recurring messages. Message and Data Rates may apply.

Service Terms:

To process your requests for this Service, you may be charged a fee to send and receive messages based on the terms of your Wireless Service Agreement. All charges are billed by and payable to your Wireless Service Provider. Check with your Wireless Service Provider if you have questions about your Wireless Service Plan.

Amgen Inc, will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your Wireless Service Provider.

This Service is available on the following carriers: AT&T, Verizon, Sprint, Virgin Mobile, Boost, T-Mobile, Metro PCS, U.S. Cellular, Aerialink, Alaska Communications Systems (ACS), Altice Mobile, ASTAC, Atlantic Tele-Network International (ATNI), bandwidth.com (includes Republic Wireless), Blue Wireless, Bluegrass Cellular, Brightlink, C Spire Wireless (aka Cellular South), Carolina West Wireless, Cellcom, Cellular One of N.E. Arizona, Chariton Valley Cellular, Chat Mobility, Copper Valley Telecom, Cordova, Cross Wireless, Digital Communications Consulting, Duet Wireless, East Kentucky Network (Appalachian Wireless), Enflick, GCI Communications, Google Voice, Illinois Valley Cellular, Inland Cellular, Inteliquent, James Valley Cellular (JVC), Limitless Mobile, Mid-Rivers Communications, MobileNation/SI Wireless, MTA Wireless/Matanuska Kenai, MTPCS Cellular One (Cellone Nation), Nemont CDMA, Nex Tech Communications, Northwest Missouri Cellular, Panhandle Wireless, Pine Belt, Pine Cellular, Pioneer Cellular, Rural Independent Network Alliance (RINA), Shelcomm, SouthernLINC, Standing Rock Telecom, Telnyx, TextMe, Thumb Cellular, Tracfone, Triangle Wireless, Truphone, Union Telephone, United Wireless, Viaero Wireless, and West Central Wireless.

T-Mobile is not liable for delayed or undelivered messages.

For questions, please call 1-833-246-6844.

Program Details:

To join Aimovig’s Migraine program go to www.mydailytracker.com or call 1-833-246-6844 to register. Fill in the required information including your mobile number and email address. You will receive an opt-in request from the short code. After you reply with the keyword START you will receive a confirmation message and be opted into the program.

You will receive recurring questions and alerts. Text HELP to 246-44 for help, STOP to 246-44 to cancel. Message and Data Rates May Apply.

TO OPT-IN TO THE SERVICE ON 246-44:
Fill out the registration form at www.mydailytracker.com. Reply START to the message you receive.
RESPONSE FROM 246-44:
Thanks! You’ll start receiving daily texts tomorrow. Msg&Data rates may apply. Reply HELP for help. Text STOP to end msgs.

To STOP (OPT-OUT OF) THE SERVICE ON 246-44:
You can cancel receipt of all SMS messages from 246-44 by replying to any service message, or sending ‘STOP’, ‘STOP ALL’, ‘END’, ‘QUIT’, ‘UNSUBSCRIBE’, or ‘CANCEL’ to 246-44.
STOP RESPONSE:
Thanks for tracking. You’ll no longer receive texts for your migraine tracker. Reply STOP ALL to opt out of all marketing texts from this sender.

TO GET HELP ON THE SERVICE ON 246-44:
You can get HELP, by replying to any service message, or sending ‘HELP’ to 246-44.
HELP RESPONSE:
Questions about your migraine tracker? Call 833-246-6844. Reply MD at any time for the migraine day definition. Reply STOP to end.

*I accept